---
layout: double
title: "New publication: Pharmacological CDK46 inhibition promotes vulnerability to lysosomotropic agents in breast cancer"
date: 2025 Feb 10
thumbnail: "'/assets/posts/pubmed_39930269.png'"
---
📖 <strong>Title:</strong> "Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer."  

🖊️ <strong>Authors:</strong> <em>Nehme J, Maassen S, Bravaccini S, Zanoni M, Gianni C, De Giorgi U, Soto-Gamez A, Altulea A, Gheorghe T, Wang B, <strong>Demaria M</strong></em>  

🏛️ <strong>Published in:</strong> <em>EMBO J</em>  

🎉 Congratulations to the authors!  

🔗 <a href="https://pubmed.ncbi.nlm.nih.gov/39930269/">View on PubMed</a>  

![Publication Image](/assets/posts/pubmed_39930269.png)
